文献速递中毒与环境急症重症综合管理与镇静镇痛

新冠合并阿片类药物过量住院患者的临床结局

Clinical outcomes of admitted patients with COVID and an opioid overdose.
PubMed 文献 · Am J Emerg Med · 2025-02-12
一句话结论急诊阿片过量住院患者中,合并新冠与住院死亡率升高(OR 2.22)和住院时间延长(IRR 1.57)相关,但与呼吸支持使用无关联。

研究利用2020年全国急诊就诊样本(NEDS)识别急诊阿片类药物过量后住院且可判定新冠感染状态的患者,主要终点为呼吸支持使用,次要终点为住院时间与死亡率。5913例合格患者中3%有新冠感染诊断;全体中28%接受呼吸支持,住院死亡率4%,平均住院时间3.9天。多变量校正后,新冠与呼吸支持使用无关联(OR 0.98;95%CI 0.67, 1.44;p=0.938),与住院死亡率升高(OR 2.22;95%CI 1.20, 4.11;p=0.011)和住院时间延长(IRR 1.57;95%CI 1.22, 2.01;p<0.001)相关。作者认为合并新冠可能增加阿片过量住院患者的并发症与住院时长,但生理机制有待未来研究。

要点

  • 5913例急诊阿片过量住院患者中3%合并新冠诊断,全体28%接受呼吸支持、住院死亡率4%、平均住院3.9天。
  • 多变量校正后新冠与呼吸支持使用无关联:OR 0.98(95%CI 0.67, 1.44;p=0.938)。
  • 新冠与住院死亡率升高相关:OR 2.22(95%CI 1.20, 4.11;p=0.011)。
  • 新冠与住院时间延长相关:IRR 1.57(95%CI 1.22, 2.01;p<0.001)。
  • 作者认为合并新冠可能导致阿片过量住院患者并发症更多、住院更长,但生理原因有待未来研究。

适用人群与场景

  • 2020年全国急诊就诊样本(NEDS)中,急诊就诊为阿片类药物过量、随后住院、且新冠感染状态可判定的患者。
  • 共5913例合格患者,其中3%有新冠感染诊断。

研究设计与关键结果

  • 研究类型:基于2020年全国急诊就诊样本(NEDS)的分析;样本量5913例;人群为急诊阿片类药物过量后住院且新冠感染状态可判定的患者。
  • 主要终点为呼吸支持使用:全体患者中28%接受呼吸支持。
  • 次要终点:住院死亡率4%,平均住院时间3.9天。
  • 多变量校正后,新冠与呼吸支持使用无关联:OR 0.98(95%CI 0.67, 1.44;p=0.938)。
  • 新冠与住院死亡率升高相关:OR 2.22(95%CI 1.20, 4.11;p=0.011)。
  • 新冠与住院时间延长相关:IRR 1.57(95%CI 1.22, 2.01;p<0.001)。

证据类型、等级与局限

  • 证据类型:基于2020年全国急诊就诊样本(NEDS)的分析。
  • 作者结论:数据提示阿片过量住院患者合并新冠感染导致并发症更多、住院时间更长,但与呼吸支持使用无关联;生理原因有待未来研究。

对床旁实践的改变

  • 对急诊阿片类药物过量住院患者,合并新冠感染可能提示住院死亡风险更高(OR 2.22;95%CI 1.20, 4.11;p=0.011)和住院时间更长(IRR 1.57;95%CI 1.22, 2.01;p<0.001),但原文未据此给出具体临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To date, research on opioid overdose during the COVID-19 pandemic has focused on rates of Emergency Department (ED) visits related to opioids but has not considered how interaction with concurrent COVID-19 infection may have influenced clinical outcomes. We hypothesized that COVID-19 infection increased the need for respiratory support, prolonged hospital stays, and increased mortality among ED patients admitted to the hospital after presenting with opioid overdose.

METHODS: The 2020 National Emergency Department Sample (NEDS) was used to identify patients admitted to the hospital after presenting to the ED with opioid overdose, and whose COVID-19 infection status could be determined. The primary outcome was the use of respiratory support, and secondary outcomes were hospital length of stay (LOS) and mortality.

RESULTS: Among the 5913 eligible patients, 3 % had a COVID-19 infection diagnosis. Among all included patients, 28 % received respiratory support, in-hospital mortality was 4 %, and the mean hospital length of stay was 3.9 days. After multivariable adjustment, COVID-19 was not associated with the use of respiratory support (odds ratio [OR]: 0.98; 95 % confidence interval [CI]: 0.67, 1.44; p = 0.938). COVID-19 was associated with higher odds of in-hospital mortality (OR: 2.22; 95 % CI: 1.20, 4.11; p = 0.011) and longer hospital stay (incidence rate ratio: 1.57, 95 % CI: 1.22, 2.01; p < 0.001).

CONCLUSION: This data suggests that COVID-19 infection in patients admitted to the hospital with opioid overdose results in higher morbidity and longer hospital stay, but had no association with the use of respiratory support. The physiologic cause deserves future study.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Gerstein B, Brewer KL, Tumin D, et al. Clinical outcomes of admitted patients with COVID and an opioid overdose. Am J Emerg Med. 2025. PMID: 39978119. doi:10.1016/j.ajem.2025.02.015

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。